Free Trial

DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to "Hold" Rating by Wall Street Zen

DENTSPLY SIRONA logo with Medical background

Key Points

  • DENTSPLY SIRONA's stock rating has been downgraded from "buy" to "hold" by Wall Street Zen, reflecting a cautious outlook from analysts.
  • The consensus rating for DENTSPLY SIRONA among analysts is currently "Hold," with an average target price of $18.64.
  • DENTSPLY SIRONA reported a quarterly earnings per share of $0.52, surpassing expectations, but its revenue has decreased by 4.9% compared to the same period last year.
  • Five stocks we like better than DENTSPLY SIRONA.

Wall Street Zen downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a buy rating to a hold rating in a research report report published on Saturday.

XRAY has been the subject of several other research reports. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. Barrington Research set a $18.00 target price on shares of DENTSPLY SIRONA and gave the stock an "outperform" rating in a report on Friday. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a report on Tuesday, April 15th. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a report on Friday, August 8th. Finally, UBS Group dropped their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a report on Friday, August 8th. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $18.64.

Read Our Latest Stock Report on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded up $0.81 during trading hours on Friday, reaching $13.86. The company had a trading volume of 1,878,927 shares, compared to its average volume of 2,987,031. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $27.48. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -2.93, a PEG ratio of 0.78 and a beta of 0.94. The firm's 50 day moving average price is $15.59 and its 200-day moving average price is $15.81.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same quarter in the previous year, the firm posted $0.49 EPS. The company's revenue for the quarter was down 4.9% compared to the same quarter last year. On average, analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.6%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -13.50%.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors have recently added to or reduced their stakes in XRAY. Mirae Asset Global Investments Co. Ltd. bought a new stake in DENTSPLY SIRONA in the first quarter worth about $25,000. Colonial Trust Co SC bought a new stake in DENTSPLY SIRONA in the fourth quarter worth about $26,000. Brooklyn Investment Group bought a new stake in DENTSPLY SIRONA in the first quarter worth about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of DENTSPLY SIRONA during the first quarter worth approximately $26,000. Finally, Trust Co. of Toledo NA OH purchased a new position in shares of DENTSPLY SIRONA during the second quarter worth approximately $27,000. Institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.